2018 – 2023 Global & French Pharma Markets

This abstract, available by clicking on this link:

  1. Reviews international healthcare expenditure
  2. Estimates the likely evolution of the global and the French pharma markets by 2023
  3. Highlights R&D expenditures and key projects
  4. Analyses the top 30 pharma companies performance and strategy (e.g. portfolio, geographical coverage, M&A)
  5. Proposes a SWOT analysis and a one-page strategic implications for pharma companies